Smith, Moore & Co. Revolution Medicines, Inc. Transaction History
Smith, Moore & Co.
- $1.17 Billion
- Q3 2025
A detailed history of Smith, Moore & Co. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Smith, Moore & Co. holds 6,000 shares of RVMD stock, worth $386,280. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,000Holding current value
$386,280% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
343Shares Held
197MCall Options Held
878KPut Options Held
693K-
Vanguard Group Inc Valley Forge, PA15.7MShares$1.01 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$922 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$863 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$682 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$661 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5.65B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...